Dietary Intake and Nutrient Status of Children With ADHD
NCT ID: NCT00434928
Last Updated: 2007-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2006-01-31
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study
NCT03252522
Biomarker Research in ADHD: the Impact of Nutrition
NCT03440346
The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01022229
Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD
NCT00307268
Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00704990
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To determine the percent consumption of low nutrient density (LND) foods
* To compare the dietary intake of ADHD children with the established standards of the Dietary Reference Intakes (DRIs)
* To compare the dietary intake of children with ADHD to the dietary recommendations of Canada's Food Guide for Healthy Eating
* To determine whether dietary intake is moderated by drug treatment
* To assess the pyridoxal-5'-phosphate (PLP), serum ferritin, serum zinc, and serum copper status of ADHD by standard laboratory blood test
* to measure height and weight in ADHD children
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 6-12 years inclusive
Exclusion Criteria
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eli Lilly and Company
INDUSTRY
University of British Columbia
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Margaret D. Weiss, MD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Provincial ADHD Program, BC Children's Hospital
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
W05-0185
Identifier Type: -
Identifier Source: secondary_id
H05-70464
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.